Guardant Health
GH
#1651
Rank
S$16.61 B
Marketcap
S$127.96
Share price
2.34%
Change (1 day)
99.34%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2025 (TTM): S-$4.23

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is S-$4.08. In 2024 the company made an earnings per share (EPS) of S-$4.53 an increase over its 2023 EPS that were of S-$5.44.

EPS history for Guardant Health from 2018 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S-$4.23-6.55%
2024S-$4.53-16.82%
2023S-$5.44-33.13%
2022S-$8.1460%
2021S-$5.0855.04%
2020S-$3.28207.14%
2019S-$1.07-19.81%
2018S-$1.33

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Neogen
NEOG
S-$3.52-13.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
S-$2.72-33.33%๐Ÿ‡บ๐Ÿ‡ธ USA